PHYSIOLOGICAL GLUCOCORTICOID LEVELS REGULATE GLUTAMINE AND INSULIN-MEDIATED GLUCOSE-METABOLISM IN SKELETAL-MUSCLE OF THE RAT - STUDIES WITH RU-486 (MIFEPRISTONE)

被引:10
作者
LEIGHTON, B
PARRYBILLINGS, M
DIMITRIADIS, G
BOND, J
NEWSHOLME, EA
DACOSTA, C
FOOT, EA
机构
[1] Department of Biochemistry, University of Oxford, Oxford OX1 3QU, South Parks Road
关键词
D O I
10.1042/bj2740187
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examined the effects of antagonism of the peak level of glucocorticoids in vivo, which occurs as rats enter the feeding/activity (dark) period on glucose and glutamine metabolism in incubated isolated rat soleus muscle preparations. Thus the rats were treated with the potent glucocorticoid antagonist RU 486 2 h before and 1 and 2 h into the dark period. Both the content of glutamine in skeletal muscle in vivo and plasma glucose and glutamine concentrations were elevated midway through the dark period, compared with the beginning of the period. RU 486 prevented the increases in plasma glucose and glutamine and caused a significant decrease in both the rate of release of glutamine in soleus muscle in vitro and the content of glutamine in gastrocnemius muscle. The sensitivity of soleus muscle to insulin in vitro is markedly decreased when isolated midway through the dark period (i.e. at 03:00 h) [Leighton, Kowalchuk, Challiss & Newsholme (1988) Am. J. Physiol. 255, E41-E45]. We now show that the concentrations of insulin required to stimulate lactate formation and glycogen synthesis half-maximally were 95 and 250-mu-units/ml respectively, and treatment of rats with RU 486 decreased these values to 55 and 90-mu-units of insulin/ml respectively. Thus antagonism of the action of the normal circadian rise in the level of glucocorticoids in rats reverses insulin insensitivity in soleus muscles in vitro.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 51 条
[1]  
BABIJ P, 1986, J PHYSIOL-LONDON, V374, pP35
[2]   EFFECT OF VENTROMEDIAL AND DORSOMEDIAL HYPOTHALAMIC-LESIONS ON CIRCADIAN CORTICOSTERONE RHYTHMS [J].
BELLINGER, LL ;
BERNARDIS, LL ;
MENDEL, VE .
NEUROENDOCRINOLOGY, 1976, 22 (03) :216-225
[3]  
Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196
[4]   HYPOTHALAMIC AND GENETIC OBESITY IN EXPERIMENTAL-ANIMALS - AUTONOMIC AND ENDOCRINE HYPOTHESIS [J].
BRAY, GA ;
YORK, DA .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :719-809
[5]   ALTERED ISLET AMYLOID POLYPEPTIDE (AMYLIN) GENE-EXPRESSION IN RAT MODELS OF DIABETES [J].
BRETHERTONWATT, D ;
GHATEI, MA ;
BLOOM, SR ;
JAMAL, H ;
FERRIER, GJM ;
GIRGIS, SI ;
LEGON, S .
DIABETOLOGIA, 1989, 32 (12) :881-883
[6]   EFFECTS OF ADRENALECTOMY AND CORTICOSTERONE ADMINISTRATION ON HYPOTHALAMIC OBESITY IN RATS [J].
BRUCE, BK ;
KING, BM ;
PHELPS, GR ;
VEITIA, MC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 243 (02) :E152-E157
[7]   INSULIN SENSITIVITY OF RATES OF GLYCOLYSIS AND GLYCOGEN-SYNTHESIS IN SOLEUS, STRIPPED SOLEUS, EPITROCHLEARIS, AND HEMI-DIAPHRAGM MUSCLES ISOLATED FROM SEDENTARY RATS [J].
CHALLISS, RAJ ;
ESPINAL, J ;
NEWSHOLME, EA .
BIOSCIENCE REPORTS, 1983, 3 (07) :675-679
[8]   AN INVESTIGATION OF THE BETA-ADRENOCEPTOR THAT MEDIATES METABOLIC RESPONSES TO THE NOVEL AGONIST BRL28410 IN RAT SOLEUS MUSCLE [J].
CHALLISS, RAJ ;
LEIGHTON, B ;
WILSON, S ;
THURLBY, PL ;
ARCH, JRS .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :947-950
[9]   EFFECTS OF THE BETA-ADRENOCEPTOR AGONIST ISOPRENALINE ON INSULIN-SENSITIVITY IN SOLEUS MUSCLE OF THE RAT [J].
CHALLISS, RAJ ;
LOZEMAN, FJ ;
LEIGHTON, B ;
NEWSHOLME, EA .
BIOCHEMICAL JOURNAL, 1986, 233 (02) :377-381
[10]   SKELETAL-MUSCLE GLYCOGEN CONTENT - DIURNAL-VARIATION AND EFFECTS OF FASTING [J].
CONLEE, RK ;
RENNIE, MJ ;
WINDER, WW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 231 (02) :614-618